Annual Retained Earnings
-$621.55 M
+$167.65 M+21.24%
31 December 2023
Summary:
BioMarin Pharmaceutical annual retained earnings is currently -$621.55 million, with the most recent change of +$167.65 million (+21.24%) on 31 December 2023. During the last 3 years, it has risen by +$240.06 million (+27.86%). BMRN annual retained earnings is now -4016.25% below its all-time high of -$15.10 million, reached on 31 December 1998.BMRN Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$319.64 M
+$106.08 M+24.92%
30 September 2024
Summary:
BioMarin Pharmaceutical quarterly retained earnings is currently -$319.64 million, with the most recent change of +$106.08 million (+24.92%) on 30 September 2024. Over the past year, it has increased by +$322.29 million (+50.21%). BMRN quarterly retained earnings is now -1530.81% below its all-time high of -$19.60 million, reached on 31 March 1999.BMRN Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.2% | +50.2% |
| 3 y3 years | +27.9% | +63.2% |
| 5 y5 years | +63.3% | +81.6% |
BMRN Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +33.2% | at high | +65.7% |
| 5 y | 5 years | at high | +63.9% | at high | +81.6% |
| alltime | all time | -4016.3% | +63.9% | -1530.8% | +82.2% |
BioMarin Pharmaceutical Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$319.64 M(-24.9%) |
| June 2024 | - | -$425.72 M(-20.1%) |
| Mar 2024 | - | -$532.89 M(-14.3%) |
| Dec 2023 | -$621.55 M(-21.2%) | -$621.55 M(-3.2%) |
| Sept 2023 | - | -$641.93 M(-5.9%) |
| June 2023 | - | -$682.31 M(-7.6%) |
| Mar 2023 | - | -$738.35 M(-6.4%) |
| Dec 2022 | -$789.20 M(-15.2%) | -$789.20 M(+0.0%) |
| Sept 2022 | - | -$788.95 M(+1.5%) |
| June 2022 | - | -$777.23 M(-3.4%) |
| Mar 2022 | - | -$804.89 M(-13.5%) |
| Dec 2021 | -$930.76 M(+8.0%) | -$930.76 M(+7.3%) |
| Sept 2021 | - | -$867.79 M(+4.4%) |
| June 2021 | - | -$831.30 M(-1.5%) |
| Mar 2021 | - | -$844.24 M(-2.0%) |
| Dec 2020 | -$861.61 M(-49.9%) | -$861.61 M(-2.5%) |
| Sept 2020 | - | -$883.71 M(-47.0%) |
| June 2020 | - | -$1.67 B(+1.8%) |
| Mar 2020 | - | -$1.64 B(-4.7%) |
| Dec 2019 | -$1.72 B(+1.6%) | -$1.72 B(-0.9%) |
| Sept 2019 | - | -$1.74 B(-3.1%) |
| June 2019 | - | -$1.79 B(+2.1%) |
| Mar 2019 | - | -$1.75 B(+3.5%) |
| Dec 2018 | -$1.69 B(+3.5%) | -$1.69 B(+0.2%) |
| Sept 2018 | - | -$1.69 B(+0.8%) |
| June 2018 | - | -$1.68 B(+1.0%) |
| Mar 2018 | - | -$1.66 B(+1.4%) |
| Dec 2017 | -$1.64 B(+7.7%) | -$1.64 B(+3.2%) |
| Sept 2017 | - | -$1.59 B(+0.8%) |
| June 2017 | - | -$1.57 B(+2.4%) |
| Mar 2017 | - | -$1.54 B(+1.1%) |
| Dec 2016 | -$1.52 B(+48.8%) | -$1.52 B(-3.3%) |
| Sept 2016 | - | -$1.57 B(+2.8%) |
| June 2016 | - | -$1.53 B(+38.3%) |
| Mar 2016 | - | -$1.11 B(+8.3%) |
| Dec 2015 | -$1.02 B(+20.2%) | -$1.02 B(-6.3%) |
| Sept 2015 | - | -$1.09 B(+9.1%) |
| June 2015 | - | -$999.26 M(+8.9%) |
| Mar 2015 | - | -$917.27 M(+7.9%) |
| Dec 2014 | -$849.77 M(+18.7%) | -$849.77 M(+8.9%) |
| Sept 2014 | - | -$779.97 M(-0.9%) |
| June 2014 | - | -$787.42 M(+4.4%) |
| Mar 2014 | - | -$753.92 M(+5.3%) |
| Dec 2013 | -$715.80 M(+32.7%) | -$715.80 M(+9.5%) |
| Sept 2013 | - | -$653.81 M(+8.8%) |
| June 2013 | - | -$600.79 M(+3.7%) |
| Mar 2013 | - | -$579.26 M(+7.4%) |
| Dec 2012 | -$539.45 M(+26.9%) | -$539.45 M(+10.9%) |
| Sept 2012 | - | -$486.44 M(+1.1%) |
| June 2012 | - | -$481.08 M(+7.1%) |
| Mar 2012 | - | -$449.07 M(+5.6%) |
| Dec 2011 | -$425.10 M | -$425.10 M(+6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | -$398.37 M(+4.6%) |
| June 2011 | - | -$380.71 M(+1.4%) |
| Mar 2011 | - | -$375.64 M(+1.2%) |
| Dec 2010 | -$371.26 M(-35.7%) | -$371.26 M(+3.4%) |
| Sept 2010 | - | -$359.08 M(-37.7%) |
| June 2010 | - | -$576.41 M(+0.1%) |
| Mar 2010 | - | -$575.93 M(-0.2%) |
| Dec 2009 | -$577.08 M(+0.1%) | -$577.08 M(-0.8%) |
| Sept 2009 | - | -$581.79 M(-1.1%) |
| June 2009 | - | -$588.44 M(-0.2%) |
| Mar 2009 | - | -$589.75 M(+2.3%) |
| Dec 2008 | -$576.60 M(-5.1%) | -$576.60 M(-4.1%) |
| Sept 2008 | - | -$601.10 M(-0.1%) |
| June 2008 | - | -$601.93 M(-0.6%) |
| Mar 2008 | - | -$605.74 M(-0.3%) |
| Dec 2007 | -$607.43 M(+2.7%) | -$607.43 M(-0.4%) |
| Sept 2007 | - | -$610.00 M(+0.9%) |
| June 2007 | - | -$604.78 M(+0.6%) |
| Mar 2007 | - | -$600.92 M(+1.6%) |
| Dec 2006 | -$591.62 M(+5.1%) | -$591.62 M(+1.8%) |
| Sept 2006 | - | -$581.23 M(+1.2%) |
| June 2006 | - | -$574.20 M(+0.2%) |
| Mar 2006 | - | -$572.87 M(+1.7%) |
| Dec 2005 | -$563.09 M(+15.2%) | -$563.09 M(+2.7%) |
| Sept 2005 | - | -$548.10 M(+2.9%) |
| June 2005 | - | -$532.62 M(+4.2%) |
| Mar 2005 | - | -$511.28 M(+4.6%) |
| Dec 2004 | -$488.82 M(+62.2%) | -$488.82 M(+20.3%) |
| Sept 2004 | - | -$406.40 M(+7.8%) |
| June 2004 | - | -$376.92 M(+17.3%) |
| Mar 2004 | - | -$321.32 M(+6.6%) |
| Dec 2003 | -$301.38 M(+33.6%) | -$301.38 M(+9.3%) |
| Sept 2003 | - | -$275.65 M(+8.4%) |
| June 2003 | - | -$254.36 M(+3.7%) |
| Mar 2003 | - | -$245.26 M(+8.7%) |
| Dec 2002 | -$225.58 M(+52.3%) | -$225.58 M(+9.4%) |
| Sept 2002 | - | -$206.25 M(+9.1%) |
| June 2002 | - | -$189.13 M(+8.2%) |
| Mar 2002 | - | -$174.72 M(+18.0%) |
| Dec 2001 | -$148.12 M(+84.0%) | -$148.12 M(+30.9%) |
| Sept 2001 | - | -$113.20 M(+10.8%) |
| June 2001 | - | -$102.18 M(+13.3%) |
| Mar 2001 | - | -$90.21 M(+12.0%) |
| Dec 2000 | -$80.51 M(+86.6%) | -$80.51 M(+14.8%) |
| Sept 2000 | - | -$70.12 M(+13.1%) |
| June 2000 | - | -$61.97 M(+12.9%) |
| Mar 2000 | - | -$54.88 M(+27.2%) |
| Dec 1999 | -$43.15 M(+185.8%) | -$43.15 M(+26.5%) |
| Sept 1999 | - | -$34.10 M(+28.7%) |
| June 1999 | - | -$26.50 M(+35.2%) |
| Mar 1999 | - | -$19.60 M |
| Dec 1998 | -$15.10 M | - |
FAQ
- What is BioMarin Pharmaceutical annual retained earnings?
- What is the all time high annual retained earnings for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual retained earnings year-on-year change?
- What is BioMarin Pharmaceutical quarterly retained earnings?
- What is the all time high quarterly retained earnings for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly retained earnings year-on-year change?
What is BioMarin Pharmaceutical annual retained earnings?
The current annual retained earnings of BMRN is -$621.55 M
What is the all time high annual retained earnings for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual retained earnings is -$15.10 M
What is BioMarin Pharmaceutical annual retained earnings year-on-year change?
Over the past year, BMRN annual retained earnings has changed by +$167.65 M (+21.24%)
What is BioMarin Pharmaceutical quarterly retained earnings?
The current quarterly retained earnings of BMRN is -$319.64 M
What is the all time high quarterly retained earnings for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly retained earnings is -$19.60 M
What is BioMarin Pharmaceutical quarterly retained earnings year-on-year change?
Over the past year, BMRN quarterly retained earnings has changed by +$322.29 M (+50.21%)